YOUR SEARCH FOR Text 261 RESULTS
111 of Total
Q4 2024 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4 2024 Incyte Corporation Earnings Conference Call Feb 10, 2025 at 8:00 AM EST Click here
112 of Total
Q4/YE 2022 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4/YE 2022 Incyte Corporation Earnings Conference Call Feb 7, 2023 at 8:00 AM EST Click here
113 of Total
Q4/Year-End 2025 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4/Year-End 2025 Incyte Corporation Earnings Conference Call Feb 10, 2026 at 8:00 AM EST
114 of Total
TD Cowen 46th Annual Health Care Conference | Incyte
Events Corporate Presentations Scientific Presentations TD Cowen 46th Annual Health Care Conference Mar 2, 2026 at 10:30 AM EST Click here for
115 of Total
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Br
View all news Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and
116 of Total
Incyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) C
View all news Incyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) Community October 13, 2026 at 1:49
117 of Total
Incyte to Present at Upcoming Investor Conferences | Incyte
View all news Incyte to Present at Upcoming Investor Conferences September 1, 2026 at 8:00 AM EDT PDF Version WILMINGTON, Del. --(BUSINESS WIRE)--Sep
118 of Total
Incyte to Report Third Quarter Financial Results | Incyte
View all news Incyte to Report Third Quarter Financial Results October 8, 2026 at 8:00 AM EDT PDF Version WILMINGTON, Del. --(BUSINESS WIRE)--Oct. 8
119 of Total
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
View all news Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs May 3, 2022 at 7:00 AM EDT PDF
120 of Total
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance
View all news Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical
A New Frontier
in Hematology
Incyte proudly adds VGA039 and the
VIVID study to its hematology portfolio.